IMMUNOPHARMA CONSULTING LTD
No Analysis Available
Get instant AI-powered insights about this company's financial health, risks, and trends.
Order Analysis - £10Financials
- Year ending
- 2024-08-31
- Total net assets
- Total liabilities
- £-36.39k£-4.19k vs previous year
- Total assets
- £0£0 vs previous year
Annual accounts
| Financial Year Ending | |
|---|---|
| 29 May 2025 | |
| 31 August 2024 | |
| 28 April 2024 | |
| 31 August 2023 | |
| 30 May 2023 | |
| 31 August 2022 | |
| 31 August 2021 | |
| 20 January 2021 | |
| 31 August 2020 | |
| 4 March 2020 | |
| 31 August 2019 | |
| 6 March 2019 | |
| 31 August 2018 | |
| 27 April 2018 | |
| 31 August 2017 | |
| 9 January 2017 | |
| 31 August 2016 | |
| 15 April 2016 | |
| 31 August 2015 | |
| 3 February 2015 | |
| 31 August 2014 | |
| 28 March 2014 | |
| 31 August 2013 | |
| 20 December 2012 | |
| 31 August 2012 | |
| 24 February 2012 | |
| 16 March 2011 | |
| 22 March 2010 |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company